Product How it works Pricing Blog FAQ About Contact
PTC Therapeutics

PTC Therapeutics (NASDAQ: PTCT) net income

PTC Therapeutics reported a net profit of $682.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $363.3m. Its net margin was 39.4%. Earnings per share were $8.58.

Fiscal 2025 is the highest of the 10 fiscal years on record for PTC Therapeutics. It reported a loss in 9 of those 10 years.

Net income, in millions of US dollars-142.12016-79.02017-128.12018-251.62019-438.22020-523.92021-559.02022-626.62023-363.32024682.62025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$682.6m—39.4%$8.58
2024−$363.3m—−45.0%−$4.73
2023−$626.6m—−66.8%−$8.37
2022−$559.0m—−80.0%−$7.79
2021−$523.9m—−97.3%−$7.43
2020−$438.2m—−115.1%−$6.64
2019−$251.6m—−82.0%−$4.27
2018−$128.1m—−48.4%−$2.75
2017−$79.0m—−40.6%−$2.02
2016−$142.1m—−171.8%—

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

PTC Therapeutics net income compared with its sector

By net income for its latest fiscal year, PTC Therapeutics ranks 54th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of PTC Therapeutics, 39.4%.

RankCompanyNet incomeNet margin
52ndDaVita$746.8m5.5%
53rdZimmer Biomet$705.1m8.6%
54thPTC Therapeutics$682.6m39.4%
55thWaters$642.6m20.3%
56thEncompass Health$566.2m9.5%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the net income of PTC Therapeutics

How much did PTC Therapeutics earn in fiscal 2025?
PTC Therapeutics reported a net profit of $682.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $363.3m.
What are the earnings per share of PTC Therapeutics?
They were $8.58 in fiscal 2025, compared with −$4.73 in fiscal 2024.
What is the net margin of PTC Therapeutics?
In fiscal 2025 its net profit was 39.4% of its revenue.
What was the most profitable year for PTC Therapeutics?
Of its last 10 fiscal years, fiscal 2025, with $682.6m.
Where does PTC Therapeutics rank in its sector by net income?
It ranks 54th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
Where do the figures for PTC Therapeutics come from?
From the annual report (Form 10-K) that PTC Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that PTC Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on PTC Therapeutics: the PTC Therapeutics page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.